Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
CNOOC
00883
| (FY)Dec 31, 2025 | (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | -2,392.12%-11.35M | ---- | -62.44%495K | ---- | 114.23%1.32M | ---- | 77.36%-9.26M | ---- | 38.15%-40.9M | ---- |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | 59.34%-331K | ---- | -147.42%-814K | ---- | -2,890.91%-329K | ---- | 56.00%-11K | ---- | 89.88%-25K | ---- |
| Interest expense - adjustment | 9.57%1.08M | ---- | -11.69%982K | ---- | 27.96%1.11M | ---- | 1.05%869K | ---- | 3.61%860K | ---- |
| Impairment and provisions: | -59.23%1.52M | ---- | 579.56%3.73M | ---- | -143.61%-778K | ---- | 162.60%1.78M | ---- | -142.07%-2.85M | ---- |
| -Other impairments and provisions | -59.23%1.52M | ---- | 579.56%3.73M | ---- | -143.61%-778K | ---- | 162.60%1.78M | ---- | -142.07%-2.85M | ---- |
| Asset sale loss (gain): | 83.32%-152K | ---- | -3,695.83%-911K | ---- | 85.00%-24K | ---- | 60.10%-160K | ---- | 44.31%-401K | ---- |
| -Loss (gain) on sale of property, machinery and equipment | 83.32%-152K | ---- | -3,695.83%-911K | ---- | 85.00%-24K | ---- | 60.10%-160K | ---- | 44.31%-401K | ---- |
| Depreciation and amortization: | -15.76%6.8M | ---- | -13.98%8.07M | ---- | -21.22%9.38M | ---- | -12.07%11.91M | ---- | -1.28%13.54M | ---- |
| -Other depreciation and amortization | -106.80%-517K | ---- | -212.50%-250K | ---- | 50.00%-80K | ---- | 0.00%-160K | ---- | 0.00%-160K | ---- |
| Special items | 393.10%143K | ---- | 93.33%29K | ---- | 116.48%15K | ---- | -479.17%-91K | ---- | 138.71%24K | ---- |
| Operating profit before the change of operating capital | -119.79%-2.29M | ---- | 8.29%11.58M | ---- | 112.35%10.69M | ---- | 116.92%5.04M | ---- | 35.09%-29.76M | ---- |
| Change of operating capital | ||||||||||
| Accounts receivable (increase)decrease | -731.01%-5.49M | ---- | 69.11%-661K | ---- | -135.46%-2.14M | ---- | -14.36%6.04M | ---- | -49.15%7.05M | ---- |
| Accounts payable increase (decrease) | 182.47%5.42M | ---- | -645.01%-6.57M | ---- | 89.11%-882K | ---- | -300.79%-8.1M | ---- | -111.65%-2.02M | ---- |
| Special items for working capital changes | -56.06%1.01M | ---- | 163.94%2.29M | ---- | -420.81%-3.58M | ---- | -92.49%1.12M | ---- | 4.65%14.86M | ---- |
| Cash from business operations | -120.51%-1.36M | -800.83%-4.21M | 62.05%6.64M | 957.14%600K | 0.12%4.1M | 95.47%-70K | 141.43%4.09M | 80.77%-1.54M | -2,108.72%-9.87M | -280.75%-8.03M |
| Net cash from operations | -120.51%-1.36M | -800.83%-4.21M | 62.05%6.64M | 957.14%600K | 0.12%4.1M | 95.47%-70K | 141.43%4.09M | 80.77%-1.54M | -2,078.56%-9.87M | -280.75%-8.03M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -59.34%331K | -45.95%260K | 147.42%814K | 2,190.48%481K | 2,890.91%329K | --21K | -56.00%11K | ---- | -89.88%25K | -89.04%25K |
| Sale of fixed assets | -84.03%152K | -82.63%152K | 3,866.67%952K | --875K | -85.00%24K | ---- | -85.84%160K | 433.33%160K | 46.37%1.13M | -51.61%30K |
| Purchase of fixed assets | 61.61%-1M | -15.51%-901K | -203.14%-2.61M | -64.21%-780K | -1,465.45%-861K | -1,150.00%-475K | 99.48%-55K | 99.15%-38K | -24.07%-10.53M | -114.08%-4.49M |
| Purchase of intangible assets | 77.27%-5K | ---- | ---22K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash from investment operations | 39.49%-524K | -184.90%-489K | -70.47%-866K | 226.87%576K | -537.93%-508K | -472.13%-454K | 101.24%116K | 102.75%122K | -173.62%-9.38M | -150.42%-4.43M |
| Net cash before financing | -132.67%-1.89M | -499.15%-4.69M | 60.86%5.77M | 324.43%1.18M | -14.72%3.59M | 63.15%-524K | 121.85%4.21M | 88.59%-1.42M | -557.45%-19.25M | -221.30%-12.46M |
| Cash flow from financing activities | ||||||||||
| Refund | 44.33%-977K | 57.12%-530K | 44.72%-1.76M | 25.41%-1.24M | 2.34%-3.18M | -2.41%-1.66M | -2.78%-3.25M | -1.57%-1.62M | -44.69%-3.16M | -53.91%-1.59M |
| Issuing shares | ---- | ---- | ---- | ---- | --14.92M | --14.92M | ---- | ---- | --21.64M | --21.26M |
| Interest paid - financing | -9.57%-1.08M | 10.51%-494K | 8.22%-982K | 7.54%-552K | -23.13%-1.07M | -38.84%-597K | -1.05%-869K | -3.37%-430K | -3.61%-860K | -9.47%-416K |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---1.12M | ---1.12M | ---- | ---- | ---377K | ---- |
| Pledged bank deposit (increase) decrease | 34.86%-327K | 18.73%-256K | -168.45%-502K | -1,400.00%-315K | -1,600.00%-187K | ---21K | 38.89%-11K | ---- | 99.58%-18K | 78.31%-18K |
| Other items of the financing business | 80.32%-197K | 30.81%-146K | -186.82%-1M | -151.19%-211K | -214.43%-349K | -138.01%-84K | 116.16%305K | 115.84%221K | -134.17%-1.89M | -298.15%-1.4M |
| Net cash from financing operations | 10.08%-8.39M | 14.85%-4.16M | -294.29%-9.33M | -153.16%-4.88M | 153.06%4.8M | 299.57%9.18M | -190.25%-9.05M | -130.22%-4.6M | 432.61%10.03M | 464.35%15.23M |
| Net Cash | -188.73%-10.27M | -138.87%-8.85M | -142.42%-3.56M | -142.79%-3.71M | 273.23%8.39M | 243.75%8.66M | 47.51%-4.84M | -317.75%-6.02M | -55.25%-9.23M | 134.33%2.77M |
| Begining period cash | -159.48%-1.33M | -159.48%-1.33M | 136.24%2.23M | 136.24%2.23M | -368.21%-6.16M | -368.21%-6.16M | -116.62%-1.32M | -116.62%-1.32M | -42.90%7.91M | -55.80%7.91M |
| Cash at the end | -774.15%-11.6M | -590.43%-10.18M | -159.48%-1.33M | -158.94%-1.47M | 136.24%2.23M | 134.08%2.5M | -368.21%-6.16M | -168.73%-7.34M | -116.62%-1.32M | 8.52%10.68M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | -- | -- | -- | -- |
| Auditor | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.